iFyber Awarded DoD Contract For Development Of Copper-Coated Wound Dressing
Ithaca, NY – iFyber, a contract research and development organization specializing in chemistry, biology, and material science, announced the award of a US Department of Defense contract to develop an antimicrobial copper coating that can be applied to a range of medical fabrics used in the production of wound dressings. This contract will enable iFyber to expand upon its prior research and development of the antimicrobial properties of functionalized copper coatings.
“We are proud to continue our development of copper coatings for the wound care market,” said by iFyber VP of R&D Aaron Strickland, PhD. “Our goal is to advance the understanding of copper as an antimicrobial and implement practical considerations for the production-scale expectations of the textile industry, who in turn supports the wound care dressings market.”
Copper has been shown to effectively inhibit growth of bacteria on surfaces and has been used in hospital and food service settings as an effective way to reduce the risk of infection. In past work shown by Dr. Strickland, copper can be chemically bound to the cellulose in cotton and reduce growth of multidrug resistant bacterial wound pathogen Acinetobacter baumannii by 8 logs (100 million fold). In its current contract with the Department of Defense, the iFyber team will optimize production parameters of the copper-textile composite and test the dressings against a wide variety of pathogenic bacteria known to infect wounds.
About iFyber:
iFyber offers unique expertise at the interface of chemistry, biotechnology and materials science. iFyber’s complementary skill sets can help customers efficiently advance innovation and address untapped markets. We thrive at the early stages of product and technology development, with a technical team that provides creative, yet practical inputs to applied problems using rigorous scientific principles, and an experienced business development team to position outcomes for market introduction under appropriate timelines.
About U.S. Army Medical Research Acquisition Activity:
The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work is supported by the Assistant Secretary of Defense for Health Affairs and the Combat Casualty Research Program through the Broad Agency Announcement under Award No. W81XWH-15-2-0066. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.
Help employers find you! Check out all the jobs and post your resume.
“We are proud to continue our development of copper coatings for the wound care market,” said by iFyber VP of R&D Aaron Strickland, PhD. “Our goal is to advance the understanding of copper as an antimicrobial and implement practical considerations for the production-scale expectations of the textile industry, who in turn supports the wound care dressings market.”
Copper has been shown to effectively inhibit growth of bacteria on surfaces and has been used in hospital and food service settings as an effective way to reduce the risk of infection. In past work shown by Dr. Strickland, copper can be chemically bound to the cellulose in cotton and reduce growth of multidrug resistant bacterial wound pathogen Acinetobacter baumannii by 8 logs (100 million fold). In its current contract with the Department of Defense, the iFyber team will optimize production parameters of the copper-textile composite and test the dressings against a wide variety of pathogenic bacteria known to infect wounds.
About iFyber:
iFyber offers unique expertise at the interface of chemistry, biotechnology and materials science. iFyber’s complementary skill sets can help customers efficiently advance innovation and address untapped markets. We thrive at the early stages of product and technology development, with a technical team that provides creative, yet practical inputs to applied problems using rigorous scientific principles, and an experienced business development team to position outcomes for market introduction under appropriate timelines.
About U.S. Army Medical Research Acquisition Activity:
The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work is supported by the Assistant Secretary of Defense for Health Affairs and the Combat Casualty Research Program through the Broad Agency Announcement under Award No. W81XWH-15-2-0066. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.
Help employers find you! Check out all the jobs and post your resume.